Studies show oral tirzepatide is effective and safe
Exercise-related soreness may improve as the body recovers and adapts
The blood pressure-lowering effects likely result primarily from weight loss, which reduces cardiac workload and peripheral vascular resistance , leading to decreased blood pressure through hemodynamic changes
The GIP receptor activation may specifically influence how the body handles fat storage and mobilization, providing a metabolic advantage beyond simple caloric restriction
Schedule a routine follow-up appointment if: Sulfur burps or other digestive symptoms persist beyond the first few weeks of a new dose Symptoms significantly impact quality of life or medication adherence Dietary modifications and conservative measures provide insufficient relief You are considering discontinuing tirzepatide due to side effects Your healthcare provider can assess whether dose adjustment, temporary treatment interruption, or additional interventions are appropriate
In other words, tirzepatide targets two receptors, whereas Semaglutide targets one receptor (GLP-1)
